Drug:
Reaction: MYELOSUPPRESSION
20250101 - 20251231
No. 1 - 100
No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
1 | 25138761 |
CN |
70 | 1 |
Myelosuppression, |
||||
DENOSUMAB, DOCETAXEL, DOCETAXEL ANHYDROUS, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, |
||||
2 | 25138985 |
JP |
1 | |
Myelosuppression, |
||||
ERIBULIN MESYLATE, |
||||
3 | 25138989 |
CN |
41 | 2 |
Myelosuppression, |
||||
GEMCITABINE HYDROCHLORIDE, |
||||
4 | 25138995 |
CN |
41 | 2 |
Myelosuppression, |
||||
CAPECITABINE, |
||||
5 | 25139079 |
CN |
52 | 2 |
Myelosuppression, |
||||
TRASTUZUMAB, PERTUZUMAB, DOCETAXEL, DOCETAXEL ANHYDROUS, CARBOPLATIN, |
||||
6 | 25139760 |
CN |
50 | 1 |
Myelosuppression, |
||||
CARFILZOMIB, |
||||
7 | 25139781 |
US |
||
Febrile neutropenia, Sepsis, Myelosuppression, |
||||
TEMOZOLOMIDE, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, ETOPOSIDE, CISPLATIN, LOMUSTINE, THIOTEPA, |
||||
8 | 25139910 |
CN |
62 | 2 |
Myelosuppression, |
||||
TRASTUZUMAB, PERTUZUMAB, |
||||
9 | 25140259 |
US |
210 | 1 |
Therapy partial responder, Myelosuppression, Febrile neutropenia, Infection, |
||||
CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, TEMOZOLOMIDE, ETOPOSIDE, |
||||
10 | 25140260 |
US |
107 | 1 |
Disease progression, Drug ineffective, Myelosuppression, Febrile neutropenia, Infection, |
||||
CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, TEMOZOLOMIDE, ETOPOSIDE, |
||||
11 | 25140275 |
US |
119 | 1 |
Septic shock, Myelosuppression, Febrile neutropenia, Sepsis, Infection, |
||||
CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, TEMOZOLOMIDE, ETOPOSIDE, |
||||
12 | 25140277 |
US |
53 | 2 |
Therapy partial responder, Septic shock, Myelosuppression, Febrile neutropenia, Sepsis, Infection, |
||||
CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, ETOPOSIDE, TEMOZOLOMIDE, |
||||
13 | 25140281 |
US |
65 | 1 |
Device related infection, Myelosuppression, |
||||
CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, TEMOZOLOMIDE, ETOPOSIDE, |
||||
14 | 25140282 |
US |
69 | 2 |
Therapy partial responder, Myelosuppression, Device related infection, |
||||
CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, TEMOZOLOMIDE, ETOPOSIDE, CISPLATIN, METHOTREXATE, METHOTREXATE SODIUM, |
||||
15 | 25140290 |
US |
36 | 1 |
Therapy partial responder, Myelosuppression, Hyponatraemia, Seizure, |
||||
CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, TEMOZOLOMIDE, ETOPOSIDE, CISPLATIN, METHOTREXATE, METHOTREXATE SODIUM, |
||||
16 | 25140958 |
CN |
||
Myelosuppression, |
||||
PACLITAXEL, |
||||
17 | 25141163 |
CN |
56 | 2 |
Myelosuppression, White blood cell count decreased, |
||||
18 | 25141220 |
CN |
7 | 1 |
Myelosuppression, Hepatic function abnormal, |
||||
CYTARABINE, METHOTREXATE SODIUM, PEGASPARGASE, DEXRAZOXANE FOR INJECTION, DEXRAZOXANE, MITOXANTRONE HYDROCHLORIDE, VINCRISTINE SULFATE, DEXAMETHASONE SODIUM PHOSPHATE, |
||||
19 | 25141239 |
CN |
59 | 2 |
Myelosuppression, Metastases to central nervous system, Acute myeloid leukaemia, Malignant neoplasm progression, Lacunar infarction, |
||||
CYTARABINE, VENETOCLAX, VENETOCLAX, VENETOCLAX, |
||||
20 | 25142352 |
CN |
47 | 2 |
Myelosuppression, |
||||
CISPLATIN, |
||||
21 | 25142538 |
CN |
61 | 2 |
Myelosuppression, |
||||
ERIBULIN MESYLATE, BEVACIZUMAB, |
||||
22 | 25137245 |
CN |
59 | 1 |
Myelosuppression, White blood cell count decreased, Neutrophil count decreased, |
||||
DOCETAXEL, DOCETAXEL ANHYDROUS, TRASTUZUMAB, PERTUZUMAB, DOCETAXEL, DOCETAXEL ANHYDROUS, PERTUZUMAB, TRASTUZUMAB, TRASTUZUMAB, TRASTUZUMAB, |
||||
23 | 25137466 |
CN |
69 | 1 |
Myelosuppression, Cerebral infarction, Haemorrhoidal haemorrhage, |
||||
VENETOCLAX, |
||||
24 | 25137514 |
CN |
71 | 2 |
Myelosuppression, |
||||
BEVACIZUMAB, PACLITAXEL, |
||||
25 | 25138056 |
CN |
59 | 2 |
Myelosuppression, |
||||
VENETOCLAX, CYTARABINE, |
||||
26 | 25132483 |
CN |
67 | |
Myelosuppression, |
||||
CARBOPLATIN, CARBOPLATIN, ETOPOSIDE, ETOPOSIDE, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, DEXTROSE MONOHYDRATE, DEXTROSE, DEXTROSE MONOHYDRATE, DEXTROSE, |
||||
27 | 25132700 |
CN |
58 | |
Myelosuppression, |
||||
28 | 25132732 |
CN |
47 | |
Myelosuppression, |
||||
REGORAFENIB, REGORAFENIB, |
||||
29 | 25132755 |
CN |
58 | |
Myelosuppression, |
||||
SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, |
||||
30 | 25132808 |
CN |
78 | |
Myelosuppression, |
||||
CARBOPLATIN, CARBOPLATIN, CARBOPLATIN, CARBOPLATIN, ETOPOSIDE, ETOPOSIDE, ETOPOSIDE, ETOPOSIDE, |
||||
31 | 25132814 |
CN |
49 | 1 |
Myelosuppression, |
||||
TRASTUZUMAB, CAPECITABINE, |
||||
32 | 25133535 |
US |
||
Febrile neutropenia, Myelosuppression, Infection, |
||||
TEMOZOLOMIDE, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, ETOPOSIDE, |
||||
33 | 25133536 |
US |
||
Febrile neutropenia, Myelosuppression, |
||||
TEMOZOLOMIDE, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, ETOPOSIDE, CISPLATIN, |
||||
34 | 25133537 |
US |
||
Febrile neutropenia, Myelosuppression, |
||||
TEMOZOLOMIDE, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, ETOPOSIDE, LOMUSTINE, CISPLATIN, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, CARBOPLATIN, THIOTEPA, ETOPOSIDE, |
||||
35 | 25133600 |
CN |
2 | |
Myelosuppression, |
||||
FRUQUINTINIB, |
||||
36 | 25133941 |
CN |
71 | 2 |
Myelosuppression, |
||||
CARFILZOMIB, DARATUMUMAB, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, |
||||
37 | 25133977 |
ES |
||
Haemolytic anaemia, Myelosuppression, |
||||
LINEZOLID, LINEZOLID, LINEZOLID, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, BELIMUMAB, METHYLPREDNISOLONE, METHYLPREDNISOLONE, |
||||
38 | 25134322 |
CN |
60 | 2 |
Therapeutic response decreased, Myelosuppression, |
||||
CARBOPLATIN, CARBOPLATIN, PEMETREXED, PEMETREXED DISODIUM, PEMETREXED, PEMETREXED DISODIUM, BEVACIZUMAB, BEVACIZUMAB, |
||||
39 | 25134326 |
IN |
2 | |
Hypokalaemia, Hypocalcaemia, Hypomagnesaemia, Myelosuppression, Fatigue, Diarrhoea, |
||||
OXALIPLATIN, LEUCOVORIN CALCIUM, FLUOROURACIL, |
||||
40 | 25134841 |
CN |
62 | 2 |
Myelosuppression, |
||||
TRASTUZUMAB, DOCETAXEL, DOCETAXEL ANHYDROUS, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, |
||||
41 | 25135410 |
CN |
62 | 2 |
Myelosuppression, |
||||
CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, |
||||
42 | 25135551 |
CN |
||
Myelosuppression, |
||||
GEMCITABINE HYDROCHLORIDE, CISPLATIN, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, |
||||
43 | 25135667 |
TW |
||
Myelosuppression, Treatment noncompliance, |
||||
DASATINIB, |
||||
44 | 25135909 |
CN |
53 | 2 |
Myelosuppression, |
||||
CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, |
||||
45 | 25136008 |
CN |
75 | |
Myelosuppression, |
||||
CARBOPLATIN, CARBOPLATIN, CARBOPLATIN, CARBOPLATIN, PACLITAXEL, PACLITAXEL, PACLITAXEL, PACLITAXEL, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, DEXTROSE MONOHYDRATE, DEXTROSE, DEXTROSE MONOHYDRATE, DEXTROSE, |
||||
46 | 25136055 |
CN |
72 | |
Myelosuppression, |
||||
CETUXIMAB, CETUXIMAB, CETUXIMAB, CETUXIMAB, |
||||
47 | 25136183 |
CN |
30 | 2 |
Myelosuppression, Product prescribing issue, Product use in unapproved indication, |
||||
REGORAFENIB, REGORAFENIB, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, |
||||
48 | 25136371 |
CN |
64 | |
Myelosuppression, Metastases to central nervous system, |
||||
PACLITAXEL, PACLITAXEL, |
||||
49 | 25136573 |
CN |
64 | |
Myelosuppression, |
||||
OXALIPLATIN, OXALIPLATIN, FLUOROURACIL, FLUOROURACIL, IDARUBICIN HYDROCHLORIDE, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, LEUCOVORIN CALCIUM, LEUCOVORIN CALCIUM, DEXTROSE MONOHYDRATE, DEXTROSE, DEXTROSE MONOHYDRATE, DEXTROSE, |
||||
50 | 25136647 |
US |
1 | |
Myelosuppression, |
||||
ASCIMINIB, |
||||
51 | 25136965 |
CN |
58 | 2 |
Myelosuppression, |
||||
ABEMACICLIB, |
||||
52 | 25137014 |
CN |
60 | 2 |
Myelosuppression, |
||||
ABEMACICLIB, |
||||
53 | 25137020 |
CN |
56 | 2 |
Myelosuppression, |
||||
ABEMACICLIB, |
||||
54 | 25137087 |
CN |
60 | 2 |
Myelosuppression, |
||||
TRASTUZUMAB, DOCETAXEL, DOCETAXEL ANHYDROUS, |
||||
55 | 25140419 |
80 | 1 | |
Pancytopenia, Thrombocytopenia, Gastric haemorrhage, Blood loss anaemia, Nephrogenic anaemia, Myelosuppression, |
||||
LINEZOLID, PIPERACILLIN SODIUM,TAZOBACTAM SODIUM, |
||||
56 | 25126395 |
CN |
68 | 2 |
Myelosuppression, |
||||
VENETOCLAX, |
||||
57 | 25126506 |
CN |
62 | 2 |
Myelosuppression, Platelet count decreased, |
||||
RITUXIMAB, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, VINCRISTINE SULFATE, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, DEXTROSE MONOHYDRATE, DEXTROSE, |
||||
58 | 25127167 |
CN |
32 | 2 |
Myelosuppression, |
||||
PERTUZUMAB, TRASTUZUMAB, DOCETAXEL, DOCETAXEL ANHYDROUS, CARBOPLATIN, |
||||
59 | 25127247 |
CN |
66 | |
Myelosuppression, |
||||
PACLITAXEL, PACLITAXEL, PACLITAXEL, |
||||
60 | 25127514 |
BR |
||
Myelosuppression, Neuropathy peripheral, Platelet count decreased, Paraesthesia, |
||||
GOLIMUMAB, GOLIMUMAB, |
||||
61 | 25127914 |
US |
||
Febrile neutropenia, Sepsis, Myelosuppression, |
||||
TEMOZOLOMIDE, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, ETOPOSIDE, CISPLATIN, ETOPOSIDE, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, METHOTREXATE, METHOTREXATE SODIUM, CARBOPLATIN, THIOTEPA, |
||||
62 | 25128603 |
US |
119 | 1 |
Septic shock, Myelosuppression, Infection, Febrile neutropenia, Sepsis, |
||||
TEMOZOLOMIDE, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, CISPLATIN, ETOPOSIDE, CARBOPLATIN, THIOTEPA, LOMUSTINE, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, |
||||
63 | 25128604 |
US |
36 | 1 |
Myelosuppression, Seizure, Hyponatraemia, |
||||
TEMOZOLOMIDE, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, CISPLATIN, ETOPOSIDE, METHOTREXATE, METHOTREXATE SODIUM, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, ETOPOSIDE, |
||||
64 | 25128605 |
US |
53 | 2 |
Sepsis, Septic shock, Myelosuppression, Infection, Febrile neutropenia, |
||||
TEMOZOLOMIDE, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, CISPLATIN, ETOPOSIDE, METHOTREXATE, METHOTREXATE SODIUM, CARBOPLATIN, THIOTEPA, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, ETOPOSIDE, ETOPOSIDE, |
||||
65 | 25128659 |
CN |
71 | 2 |
Myelosuppression, |
||||
DARATUMUMAB, CARFILZOMIB, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, |
||||
66 | 25129048 |
CN |
22 | 1 |
Myelosuppression, Disseminated varicella zoster virus infection, Hepatic enzyme increased, |
||||
METHYLPREDNISOLONE ACETATE, |
||||
67 | 25129960 |
CN |
66 | 2 |
Myelosuppression, Pyrexia, Diarrhoea, Fatigue, Asthenia, Discomfort, |
||||
CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, DOCETAXEL, DOCETAXEL ANHYDROUS, DOCETAXEL, DOCETAXEL ANHYDROUS, |
||||
68 | 25130097 |
CN |
||
Myelosuppression, |
||||
CARBOPLATIN, PEMETREXED DISODIUM, PEMETREXED, |
||||
69 | 25130116 |
CN |
14 | 1 |
Myelosuppression, Hepatic function abnormal, Drug-induced liver injury, |
||||
CYTARABINE, |
||||
70 | 25130611 |
CN |
4 | 1 |
Liver injury, Hepatic enzyme increased, Myelosuppression, Pyrexia, Infection, |
||||
IFOSFAMIDE, ETOPOSIDE, CYTARABINE, METHOTREXATE, METHOTREXATE SODIUM, |
||||
71 | 25130612 |
CN |
8 | 2 |
Myelosuppression, |
||||
IFOSFAMIDE, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, ETOPOSIDE, GEMCITABINE HYDROCHLORIDE, PACLITAXEL, |
||||
72 | 25130746 |
CN |
18 | 1 |
Myelosuppression, Neutropenia, Coagulopathy, Off label use, |
||||
DARATUMUMAB, VENETOCLAX, |
||||
73 | 25131386 |
CN |
65 | 2 |
Myelosuppression, |
||||
ABEMACICLIB, |
||||
74 | 25131511 |
ES |
1 | |
Drug-induced liver injury, Myelosuppression, Drug interaction, Drug ineffective, |
||||
PEMETREXED, PEMETREXED DISODIUM, PACLITAXEL, VINORELBINE, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, MIRTAZAPINE, APIXABAN, CEFTRIAXONE, CEFTRIAXONE SODIUM, TRIMETHOPRIM, ALPRAZOLAM, PEMBROLIZUMAB, AMIKACIN, CARBOPLATIN, AZITHROMYCIN, AZITHROMYCIN MONOHYDRATE, AZITHROMYCIN DIHYDRATE, LINEZOLID, LINEZOLID, LINEZOLID, LINEZOLID, |
||||
75 | 25131512 |
CN |
57 | 2 |
Myelosuppression, Product prescribing issue, Incorrect dose administered, |
||||
REGORAFENIB, |
||||
76 | 25131518 |
CN |
59 | 1 |
Myelosuppression, Drug eruption, |
||||
CYTARABINE, CYTARABINE, IDARUBICIN HYDROCHLORIDE, IDARUBICIN HYDROCHLORIDE, |
||||
77 | 25131795 |
CN |
59 | 2 |
Myelosuppression, |
||||
CARBOPLATIN, |
||||
78 | 25120983 |
CN |
55 | 1 |
Myelosuppression, Coma, |
||||
CISPLATIN, |
||||
79 | 25120985 |
CN |
64 | 2 |
Myelosuppression, |
||||
80 | 25121036 |
CN |
67 | |
Myelosuppression, Off label use, |
||||
ZANUBRUTINIB, |
||||
81 | 25121123 |
CN |
55 | |
Myelosuppression, |
||||
GEMCITABINE HYDROCHLORIDE, GEMCITABINE HYDROCHLORIDE, DEXAMETHASONE SODIUM PHOSPHATE, DEXAMETHASONE SODIUM PHOSPHATE, |
||||
82 | 25121329 |
CN |
28 | |
Myelosuppression, |
||||
CISPLATIN, ETOPOSIDE, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, |
||||
83 | 25121586 |
CN |
53 | |
Myelosuppression, |
||||
PACLITAXEL, PACLITAXEL, |
||||
84 | 25121633 |
CN |
39 | |
Myelosuppression, |
||||
CISPLATIN, CISPLATIN, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, |
||||
85 | 25121738 |
CN |
67 | |
Myelosuppression, |
||||
86 | 25121747 |
CN |
61 | |
Myelosuppression, |
||||
87 | 25121761 |
CN |
71 | |
Myelosuppression, |
||||
GEMCITABINE HYDROCHLORIDE, GEMCITABINE HYDROCHLORIDE, BEVACIZUMAB, BEVACIZUMAB, |
||||
88 | 25122003 |
CN |
52 | 2 |
Myelosuppression, |
||||
TRASTUZUMAB, PERTUZUMAB, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, |
||||
89 | 25122018 |
CN |
57 | 2 |
Myelosuppression, Off label use, |
||||
PACLITAXEL, CARBOPLATIN, TRASTUZUMAB, PERTUZUMAB, |
||||
90 | 25122084 |
CN |
74 | 2 |
Pleural effusion, Hydrothorax, Cough, Sputum discoloured, Dyspnoea, Asthenia, Decreased appetite, Pulmonary mass, Lymphadenopathy, Chest discomfort, Myelosuppression, Agranulocytosis, Platelet count decreased, Abdominal pain, Vomiting, |
||||
OXALIPLATIN, |
||||
91 | 25122594 |
CN |
55 | 2 |
Myelosuppression, |
||||
CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, DEXTROSE MONOHYDRATE, DEXTROSE, EPIRUBICIN HYDROCHLORIDE, |
||||
92 | 25122956 |
CN |
68 | |
Myelosuppression, |
||||
OLAPARIB, BEVACIZUMAB, |
||||
93 | 25123375 |
CN |
62 | |
Myelosuppression, |
||||
OLAPARIB, BEVACIZUMAB, |
||||
94 | 25123639 |
CN |
62 | 2 |
Myelosuppression, |
||||
TRASTUZUMAB, OXALIPLATIN, |
||||
95 | 25123643 |
CN |
43 | 2 |
Myelosuppression, Neutrophil count decreased, White blood cell count decreased, Platelet count decreased, Blood pressure increased, |
||||
TRASTUZUMAB, CARBOPLATIN, DOCETAXEL, DOCETAXEL ANHYDROUS, |
||||
96 | 25123657 |
CN |
32 | 2 |
Myelosuppression, |
||||
PERTUZUMAB, TRASTUZUMAB, CARBOPLATIN, DOCETAXEL, DOCETAXEL ANHYDROUS, |
||||
97 | 25123958 |
CN |
3 | 1 |
Myocardial injury, Myelosuppression, Hepatic function abnormal, Coagulopathy, |
||||
BLINATUMOMAB, BLINATUMOMAB, PREDNISONE, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, CYTARABINE, PEGASPARGASE, PEGASPARGASE, METHOTREXATE, METHOTREXATE SODIUM, VENETOCLAX, VENETOCLAX, DECITABINE, AZACITIDINE, AZACITIDINE FOR, |
||||
98 | 25124283 |
CN |
22 | 2 |
Myelosuppression, |
||||
CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, DEXTROSE MONOHYDRATE, DEXTROSE, RITUXIMAB, RITUXIMAB, DOXORUBICIN HYDROCHLORIDE, DOXORUBICIN, DOXORUBICIN HYDROCHLORIDE, DOXORUBICIN, VINCRISTINE SULFATE, VINCRISTINE SULFATE, |
||||
99 | 25124438 |
CN |
76 | 1 |
Myelosuppression, |
||||
DENOSUMAB, |
||||
100 | 25124476 |
CN |
42 | 2 |
Myelosuppression, Decreased appetite, Asthenia, Tachypnoea, |
||||
EXEMESTANE, EXEMESTANE, ABEMACICLIB, ABEMACICLIB, |
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2025-04-28